Annette Marcantonio
Corporate Officer/Principal bei JASPER THERAPEUTICS, INC.
Profil
Annette Marcantonio is currently the Vice President of Clinical Operations at Jasper Therapeutics, Inc. Prior to this, she held the same position at Aimmune Therapeutics, Inc. from 2016 to 2020.
She received her undergraduate degree from Loyola Marymount University.
Aktive Positionen von Annette Marcantonio
Unternehmen | Position | Beginn |
---|---|---|
JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 02.08.2023 |
Ehemalige bekannte Positionen von Annette Marcantonio
Unternehmen | Position | Ende |
---|---|---|
AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2020 |
Ausbildung von Annette Marcantonio
Loyola Marymount University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JASPER THERAPEUTICS, INC. | Finance |
Private Unternehmen | 1 |
---|---|
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |